Trial
NCT00127114
Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Dementia
Intervention
Amantadine
Why stopped
No funding and exclusion criteria were to stringent.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-14